Avalo Therapeutics, Inc.

NASDAQ:AVTX

Biotechnology

Healthcare
$6.70 -2.18%

-$0.34 today

Market cap
$387.41M
Beta
0.82
P/E (TTM)
-3.6
EPS (TTM)
-$4.21
52W Low $4.50High $24.27

Volume 1.58M

Average 1.61M

Price history

Avalo Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-61.91%

Period high

$22.87

Period low

$6.63

Latest

$6.70

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 13, 2026Nov 13, 2026
SC 13GNov 10, 2026Nov 10, 2026
SC 13G/ANov 6, 2026Nov 6, 2026
SC 13G/ANov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
424B5Nov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
S-3ASRNov 5, 2026Nov 5, 2026
SC 13GOct 29, 2026Oct 29, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 11, 2026Sep 11, 2026

Competitors

Who does Avalo Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about AVTX's filings, answered from its disclosures.

What is the latest AVTX filing?

The latest filing shown is SC 13G dated Nov 13, 2026.

How many recent filings does AVTX have?

Intrinsic Alpha currently shows 20 recent filings for AVTX.